This study aims to investigate whether FBXW7 controls high-mobility group box 1 protein (HMGB1)-mediated innate immune signaling to improve NAFLD and the mechanism underlying this action. This evidence concerns the gene HMGB1 and metabolic dysfunction-associated steatotic liver disease.